The following criteria is provided for health care professionals.

Inclusion Criteria:

• Patient is ≥ 18 years old with a diagnosis of Multiple Myeloma
• Patient must reside in the USA.
• Patients within each of the following subgroups, at one of the following timepoints, will be eligible for entry:
  1. Newly-diagnosed multiple myeloma transplant-eligible
  2. Patients undergoing their first ASCT
  3. Newly-diagnosed multiple myeloma transplant-ineligible
  4. Relapsed and/or refractory.

Exclusion Criteria:

• Patient has a condition(s) that, in the opinion of the Investigator, would make participation infeasible such as inability to provide informed consent, illiteracy, or inability to speak, read, and write in English.
• Patient is on hospice.
• Patient is receiving or has received an investigational agent < 28 days prior to randomization or during this pilot study.